The hedge fund is trying to decide whether to make the apparent arbitrage opportunity exists the risk that the acquisition of Abbott Labs ALZA.
This case is only available in paper format (HBP do not have the rights to distribute digital content). As a result, a digital copy of an educator if not available through this Web site. "Hide
by George Chacko, Randolph B. Cohen, Andrew Coleman, Mark Chenault Source: Harvard Business School 30 pages. Publication Date: March 28, 2003. Prod. #: 203003-HCB-ENG
Related Case Solutions & Analyses:
NTT DoCoMo (TM): Value Innovation at DoCoMo
Butler Shine Stern & Partners
American National Red Cross (B)
ConAgra Inc.: Across the Food Chain
The Upside of Messiness: Clumsy Solutions for Wicked Problems
Balanced Workplace Flexibility: Avoiding the Traps
Negotiating with the Cuban Sugar Industry (A): No Way Out?
HgCapital and the Visma Transaction (A)
Managing Knowledge at Booz-Allen and Hamilton: Knowledge On-Line and Off (A)
The House that Branson Built: From Counter-culture to Corporate Culture
